High Growth Tech Stocks to Watch in February 2025
As global markets navigate a landscape of tariff uncertainties and mixed economic signals, with U.S. stocks ending the week lower despite strong earnings reports from many companies, investors are ...
Institute for Protein Innovation Receives Grant from Chan Zuckerberg Initiative to Develop Next-Generation Protein Tools for Neuroscience Research
The Institute for Protein Innovation (IPI), a nonprofit research institute dedicated to advancing protein science, today announced that it received a $500,000 grant from the Chan Zuckerberg Initiative ...
Serum Free And Specialty Media Market To Reach $6.9 Billion, Globally, By 2033 At 11.6% CAGR: Allied Market Research
Request Sample of the Report on Global Serum Free and Specialty Media Market 2033 - Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies, and rise ...
Zacks Small Cap Research on MSN6d
DYAI: Looking Toward Product Revenues
DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) enters 2025 on the cusp of generating product revenues from its relationship with Proliant. Initially, commercialization ...
chromatographyonline6d
Looking to the Future of Bispecific Antibody Productio
A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.
Ever-Growing USA on MSN6d
Cell Line Development Process – Challenges and Best Practices
Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.
eLife2d
Enalapril mitigates aging by targeting antioxidative genes via phosphorylated Smad1/5/9
In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...
Scientific Research Publishing6d
Recombinant IgM expression in mammalian cells: A target protein challenging biotechnological production ()
A panel of mammalian cell lines is suitable for the production of biopharmaceuticals [22] exist but the main workhorses for recombinant protein production are Chinese hamster ovary (CHO) cells. They ...
Biopharmaceutical Contract Manufacturing Market To Reach USD 25.1 Billion By 2034 At A 8.8% Of CAGR
Biopharmaceutical Contract Manufacturing Market Biopharmaceutical Contract Manufacturing Learn how outsourcing trends in biopharma m ...
PharmiWeb3d
Active Pharmaceutical Ingredient (API) Market Size, Share and Growth Report 2025-2034
Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...
Demand for CSL’s Plasma Products Persists as Supply Improves
CSL’s balance sheet is in sound condition. Financial risk is low given low revenue cyclicality and product demand is being largely driven by chronic indications. We forecast CSL’s net debt to EBITDA ...
Diamyd Medical AB: Diamyd Medical announces expanded financial support from Breakthrough T1D
Diamyd Medical will receive USD 1.75 million in expanded collaboration support from Breakthrough T1D (formerly JDRF), the world's leading Type 1 Diabetes ...